Development of efficent gene therapy for the treatment of erythrocyte pyruvate kinase deficiency

被引：1
|
作者：
Meza, Nestor W. [2 ]
Alonso, Maria Eugenia [1 ]
Navarro, Susana [1 ]
Guenechea, Guillermo [1 ]
Quintana-Bustamante, Oscar [1 ]
Garcia-Gomez, Maria [1 ]
Bueren, Juan A. [1 ]
Bautista, Jose M. [3 ]
Segovia, Jose C. [1 ]
机构：
[1] CIEMAT, Hematopoiesis & Gene Therapy Div, Madrid, Spain
[2] Univ Los Andes, Sch Med Tachira, LABIEMET, San Cristobal, Venezuela
[3] UCM, Fac Vet, Dept Biochem & Mol Biol, Madrid, Spain
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2584.2584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2584
引用
收藏
页码：761A / 762A
页数：2
相关论文
共 50 条
  • [1] Efficient gene therapy for the treatment of erythrocyte pyruvate kinase deficiency
    Meza, Nestor W.
    Alonso, Maria E.
    Navarro, Susana
    Guenechea, Guillermo
    Quintana-Bustamante, Oscar
    Garcia-Gomez, Mara
    Bueren, Juan A.
    Bautista, Jose M.
    Segovia, Jose C.
    HUMAN GENE THERAPY, 2007, 18 (10) : 959 - 959
  • [2] Gene therapy of the human erythrocyte pyruvate kinase deficiency.
    Segovia, JC
    Meza, NW
    Quintana-Bustamante, O
    Puyet, A
    Rio, P
    Bueren, JA
    Bautista, JM
    BLOOD, 2004, 104 (11) : 454A - 454A
  • [3] Gene Therapy of Pyruvate Kinase Deficiency
    Carlos Segovia, Jose
    HUMAN GENE THERAPY, 2009, 20 (09) : 1033 - 1034
  • [4] Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency
    Garcia-Gomez, Maria
    Calabria, Andrea
    Garcia-Bravo, Maria
    Benedicenti, Fabrizio
    Kosinski, Penelope
    Lopez-Manzaneda, Sergio
    Hill, Collin
    del Mar Manu-Pereira, Maria
    Martin, Miguel A.
    Orman, Israel
    Vives-Corrons, Joan-LLuis
    Kung, Charles
    Schambach, Axel
    Jin, Shengfang
    Bueren, Juan A.
    Montini, Eugenio
    Navarro, Susana
    Segovia, Jose C.
    MOLECULAR THERAPY, 2016, 24 (07) : 1187 - 1198
  • [5] Preclinical biosafety studies of lentiviral vector-mediated gene therapy in erythrocyte pyruvate kinase deficiency
    Quintana-Bustamante, O.
    Sanchez-Dominguez, R.
    Garcia-Torralba, A.
    Alberquilla, O.
    Lopez-Manzaneda, S.
    Fananas, S.
    Nieto, V.
    Molinos, A.
    Garcia-Bravo, M.
    Yanez, R.
    Bueren, J. A.
    Navarro, S.
    Segovia, J. C.
    HUMAN GENE THERAPY, 2018, 29 (12) : A39 - A39
  • [6] Development and Validation of a GMP Grade Lentiviral Vector for the Gene Therapy of Pyruvate Kinase Deficiency
    Navarro, Susana
    Trigueros, Cesar
    Quintana-Bustamante, Oscar
    Villanueva, Mariela S.
    Lopez-Manzaneda, Sergio
    Bueren, Juan A.
    Ramirez, Juan C.
    Segovia, Jose C.
    MOLECULAR THERAPY, 2017, 25 (05) : 126 - 126
  • [7] DEVELOPMENT OF RETROVIRAL VECTORS FOR GENE-THERAPY OF CANINE PYRUVATE-KINASE DEFICIENCY
    WHITNEY, KM
    ABRAHA, T
    LOTHROP, CD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 415 - 415
  • [8] Lentiviral-based gene therapy for Pyruvate Kinase deficiency
    Garcia-Gomez, M.
    Navarro, S.
    Orman, I.
    Angel Martin, M.
    Garcia-Bravo, M.
    Bueren, J. A.
    Antoniou, M.
    Segovia, J. C.
    HUMAN GENE THERAPY, 2013, 24 (12) : A111 - A111
  • [9] ACQUIRED DEFICIENCY OF ERYTHROCYTE PYRUVATE-KINASE IN AML
    PRCHAL, JT
    GAMS, RA
    BLOOD, 1977, 50 (05) : 229 - 229
  • [10] MOLECULAR MECHANISM OF ERYTHROCYTE PYRUVATE-KINASE DEFICIENCY
    KAHN, A
    MARIE, J
    GALAND, C
    BOIVIN, P
    HUMANGENETIK, 1975, 29 (04): : 271 - 280
12345